Difference between revisions of "Miele E, et al. BMC Cancer (2017) cited as Ref 271 in DOI: 10.1038/s41392-020-0110-5 (Q9534)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2017, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Page(s) (P105): 488-, #quickstatements; #temporary_batch_1590074839150) |
||
(3 intermediate revisions by the same user not shown) | |||
Property / Published In Name String | |||
+ | BMC Cancer | ||
Property / Published In Name String: BMC Cancer / rank | |||
+ | Normal rank | ||
Property / Volume | |||
+ | 17 | ||
Property / Volume: 17 / rank | |||
+ | Normal rank | ||
Property / title | |||
+ | beta-Arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells (English) | ||
Property / title: beta-Arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells (English) / rank | |||
+ | Normal rank | ||
Property / Page(s) | |||
+ | 488- | ||
Property / Page(s): 488- / rank | |||
+ | Normal rank |
Latest revision as of 15:36, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Miele E, et al. BMC Cancer (2017) cited as Ref 271 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Miele E
0 references
2017
0 references
BMC Cancer
0 references
17
0 references
beta-Arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells (English)
0 references
488-
0 references